GLP-1 agonists commonly cause nausea, vomiting, diarrhea, and abdominal painsymptoms that overlap with Crohn's disease
The pill and the injection are not different drugs with different chemistry
BCBS Ozempic Coverage Updates Its worth noting that some BCBS plans have recently tightened, or even stopped, coverage for GLP-1 drugs for individuals without type 2 diabetes, although they continue to cover them for patients with a diagnosis of type 2 diabetes
#Type2Diabetes #DiabetesCare #GLP1 #DPP4 #GlycaemicControl #WeightManagement #CardiovascularHealth To view or add a comment, sign in Association between eating behavior patterns and the therapeutic efficacy of GLP-1 receptor agonists in individuals with type 2 diabetes: a multicenter prospective observational study To view or add a comment, sign in The recent meeting of the European Association for the Study of Diabetes - European Association for the Study of Diabetes e.V
The 30-year-old Queens resident started gaining weight during the COVID pandemic as her lifestyle became more sedentary
Other effects may include overstimulation of growth hormone and cardiovascular and metabolic concerns